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ivision, SA Health, Government of South Australia, Adelaide, South Australia, AustraliaA B S T R A C TObjective: Computed tomography colonography (CTC) is an alterna-
tive diagnostic test to colonoscopy for colorectal cancer and polyps.
The aim of this study was to determine test characteristics important
to patients and to examine trade-offs in attributes that patients are
willing to accept in the context of the diagnosis of colorectal cancer.
Methods: A discrete choice study was used to assess preferences of
patients with clinical indications suspicious of colorectal cancer who
experienced both CTC and colonoscopy as part of a diagnostic accuracy
study in South Australia. Results were analyzed by using a mixed logit
model and presented as odds ratios (ORs) for preferring CTC over
colonoscopy. Results: Colonoscopy was preferred over CTC as the
eed for a second procedure after CTC increased (OR of preferring CTC
o colonoscopy  0.013), as the likelihood of missing cancers or polyps
ncreased (OR of preferring CTC to colonoscopy 0.62), and as CTC test
ost increased (OR of preferring CTC to colonoscopy  0.65–0.80). CTC
o rep
blic
al So
doi:10.1016/j.jval.2011.07.012would be preferred to colonoscopy if a minimal bowel preparation was
available (OR 1.7). Some patients were prepared to trade off the diag-
nostic and therapeutic advantage of colonoscopy for a CTC study with
a less intensive bowel preparation. Preferences also varied significantly
with sociodemographic characteristics. Conclusions: Despite CTC’s
often being perceived as a preferred test, this may not always be the
case. Informed decision making for diagnostic tests for colorectal can-
cer should include discussion of the benefits, downsides, and uncer-
tainties associated with alternative tests, as patients are willing and
able to make trade-offs between what they perceive as the advantages
and disadvantages of these diagnostic tests.
Keywords: colonoscopy, colorectal cancer, CT colonography, discrete
choice experiments, patient preference.
Copyright © 2011, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Computed tomography colonography (CTC), also known as virtual
colonoscopy, has been advocated as a possible alternative diag-
nostic test to colonoscopy for colorectal cancer (CRC) and polyps,
on the basis that it is less invasive and therefore more acceptable
to patients. However, there remain a number of important differ-
ences between CTC and colonoscopy [1]. Diagnostic accuracy
studies generally favor colonoscopy [2–4]. Patients who have le-
sions found at CTC will subsequently be advised to have conven-
tional colonoscopy. However, patients with no lesions at CTC will
usually avoid a colonoscopy. The procedures also vary in patient
discomfort, use of sedation, rates of complications, and, for CTC,
the identification of extracolonic findings that may require inves-
tigation and treatment. At present, bowel preparation is similar
for both CTC and colonoscopy, but potential developments in fecal
tagging or fecal subtraction techniques may eventually permit less
intensive regimens in patients having CTC [5]. Finally, the two
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Published by Elsevier Inc.procedures use different health system resources and there may
be differences in costs to insurance providers or to patients. These
differences suggest that patients deciding between CTC and
colonoscopy as diagnostic tests will need to make trade-offs be-
tween the perceived advantages and disadvantages of each test,
and patient preferences should therefore be an important deter-
minant of test choice [6,7].
Comparisons of patient experiences with both procedures are
highly variable and range from less discomfort and difficulty with
CTC to similar experiences with both procedures to less discom-
fort with colonoscopy [8–17]. Patients consistently report concerns
over the inconvenience and discomfort associated with bowel
preparations [10–15,18,19].
A number of studies have examined consumer preferences for
CTC and colonoscopy (as well as tests such as fecal occult blood
tests) as screening tests for CRC [20–22]. Our study, however, spe-
cifically considers patient preferences for CTC and colonoscopy as
diagnostic tests, that is, in patients with clinical indications sug-
ort.
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ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
1147V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 4 6 – 1 1 5 2gestive of CRC. It is unclear whether existing evidence on con-
sumer preferences generated in the context of CRC screening is
applicable to the context of clinical diagnosis. Given differences in
respondent populations (patients with clinical indications sug-
gesting CRC, rather than asymptomatic, well, general population
respondents), there are likely to be differences in the relative im-
portance of attributes and in the benefit/harm trade-offs that are
acceptable to patients in the diagnostic compared with screening
contexts.
In this study of patient preferences for diagnostic tests for CRC,
we have used a discrete choice experiment (DCE) to 1) identify the
extent to which the attributes of a test such as test accuracy or
type of bowel preparation affected test preference; 2) determine
the relative importance of these attributes; and 3) explore the ex-
tent to which patients are willing to make trade-offs between the
perceived advantages and disadvantages of the tests in choosing
their preferred diagnostic test for CRC.
Methods
We assessed patient preferences for CTC and colonoscopy in 130
patients who had recently undergone both tests as part of a diag-
nostic accuracy study [23]. Participants had indications appropri-
ate for diagnostic colonoscopy, including bowel symptoms, posi-
tive fecal occult blood test results, or a family history of CRC.
Discrete choice experiments
Patient preferences were assessed by using a DCE [24–26]. The
method is based on the idea that goods and services, including
health-care services, can be described in terms of a number of
separate attributes or factors. For example, a diagnostic test may
be described in terms of the false-negative rate, the false-positive
rate, costs, or other factors, such as whether it can be performed in
an inpatient or outpatient setting. The levels of attributes are var-
ied systematically in a series of questions, and respondents
choose the option that they prefer for each question. People are
assumed to choose the option that is most preferred, or has the
highest “value.” From these choices, a mathematical function is
estimated that describes numerically the value that respondents
attach to different choice options. Other data collected in the sur-
vey, including attitudinal questions and sociodemographic infor-
mation, may also enter the value functions as explanatory vari-
ables. Ultimately, DCE studies can determine which attributes are
driving patient preferences, the trade-offs between attributes that
people are willing to accept, and how changes in attributes can
lead to changes in preferences and likely service uptake. Recent
publications outline considerations for design and analysis of
such studies, and these suggested methods have been followed
here [24–26].
Table 1 – Attributes and levels for CTC and colonoscopy.
Description
How likely it is that you will need a second procedure after
CTC to treat polyps or cancer
Bowel preparation
Test accuracy (likelihood of missing small cancers or polyps)
The one-off cost to you personallyCTC, computed tomography colonography.Identifying the attributes
A systematic review of the literature of patient experiences and
preferences for CTC and colonoscopy and face-to-face interviews
with 14 patients who had experienced both CTC and colonoscopy
were used to identify attributes. Ten candidate attributes were
identified: out-of-pocket cost, test accuracy (missing cancers or
polyps), ability to perform therapeutic procedures, need for a sec-
ond test/procedure versus only having one procedure, having a
general anesthetic, ability to leave hospital by yourself, type of
bowel preparation, level of discomfort, exposure to radiation, and
time required to perform the test. It is not feasible to include every
attribute that is important to every respondent, but attributes
should include factors that are the most salient for the majority
and the most relevant to policymaking [24,26]. As the number of
attributes increases, so does task complexity and respondent bur-
den; therefore, the number of attributes included should be bal-
anced against these issues [24,26]. The 14 patients plus eight doc-
tors (radiologists, gastroenterologists, and surgeons) ranked these
attributes in terms of importance, and we calculated the mean
rank for each attribute for doctors and for patients. The ordering of
importance was comparable between patients and doctors. By us-
ing this ranking, and focusing on attributes for which the levels were
different between the two tests, we used the four most highly ranked
attributes in the DCE: likelihood of needing a second therapeutic pro-
cedure after CTC to treat polyps or cancer, the type of bowel prepa-
ration (intensive or minimal), the test accuracy (specifically the false-
negative rate or the likelihood of missing a small cancer or a polyp),
and out-of-pocket cost (Table 1).
Calculation of attribute levels
Attribute levels for the “likelihood of needing a second procedure
after CTC to treat polyps or cancer” and “chance of missing can-
cers or polyps” were presented as absolute frequencies [27–29].
Attribute levels for the “likelihood of needing a second procedure”
were based on the test positivity rates from the clinical literature
for CTC [30–37], which ranged from approximately 20% to 40%.
Assuming that all positive CTC studies are followed by a colonos-
copy, 20% to 40% of those undergoing a CTC would require a
colonoscopy for possible therapeutic intervention. The levels and
description for the bowel preparation attribute were based on pa-
tient information on bowel preparations used at the hospital
where patients underwent the diagnostic tests; minimal bowel
preparation was presented as having only minimal diarrhea. Test
accuracy was presented as the absolute number of people who
have cancers or polyps missed as a proportion of all those who
undergo the tests. It was calculated on the basis of the test posi-
tivity rates of 20% to 40% [30–37] and the false-negative rates for
colonoscopy and CTC [38–42]. The levels of the out-of-pocket cost
attribute were based on the fact that at the time of the study,
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ever, was not subsidized and, therefore, was associated with an
out-of-pocket cost of up to $300 (telephone survey of private radi-
ology providers).
Design of the DCE
The DCE consisted of three attributes with two levels and one
attribute with four levels for CTC and a fixed colonoscopy option
(one level for each attribute). For each DCE question, the attribute
levels were varied for the CTC option (Table 1) and remained fixed
for colonoscopy, representing the status quo at the time. A full
factorial design with 32 choice sets was developed (D-error of
0.001). In each question, patients chose between two labeled alter-
natives: CTC or colonoscopy; a “choose neither test” option was
not included because tests were being evaluated in patients re-
quiring some diagnostic investigation for CRC. Because patients
had experienced both tests as part of the diagnostic accuracy
study and were familiar with the name and characteristics of both
tests, we used a labeled design.
Pilot study
We conducted a pilot study of the DCE in 10 people who had ex-
perienced both CTC and colonoscopy as part of a pilot for the
diagnostic accuracy trial [23]. Results indicated that respondents
ere able to understand attribute descriptions and levels and
omplete the 32 discrete choice questions without undue burden.
Study format and sample
The DCE was mailed to 154 consecutive patients approximately 4
weeks after they had a CTC and same-day colonoscopy as part of
the diagnostic accuracy study [23]. Participants could complete the
uestionnaire themselves or be interviewed by telephone by a re-
earch nurse. Those who chose to be interviewed by telephone
ere asked to refer to the paper copy of the questionnaire at the
ime of the interview. The interview schedule included a description
f the attributes, a practice discrete choice exercise to familiarize
espondents with the format, and interpretation of the attributes
ollowed by discrete choice questions and sociodemographic ques-
ions. Respondents nominated their preferred test for each of the 32
ypothetical questions (see Table 2 for example question). The study
as approved by the University of Sydney Human Research Ethics
ommittee and the Northwestern Adelaide Health Service Ethics of
uman Research Committee, and individual informed consent was
btained from all respondents.
Analysis
We used a mixed logit model to analyze patient preferences. A
mixed logit model is a logistic regression model where different
regression parameters (s) are estimated for each respondent,
Table 2 – Example of choice question.
Example scenario
How likely it is that you will need a second procedure after
CTC to treat polyps or cancer
Bowel preparation
Test accuracy (likelihood of missing small cancers or polyps)
The one-off cost to you personally
Which test would you choose?CTC, computed tomography colonography.hereby better capturing the true decision-making profile of re-
pondents. In DCE, the respondent is assumed to choose the
lternative in each question that leads to the higher level of
alue. The value function has an outcome (dependent) variable
nd explanatory variables. The outcome variable is the choice
etween two or more alternatives made by respondents for each
uestion, whereas explanatory variables are the attributes used
o describe the tests, or other observed characteristics of re-
pondents such as demographics. Additional discussion of the
ixed logit approach and DCEs more generally is available else-
here [24,26,43,44].
Interactions between attributes, and between attributes and
patient characteristics (age, sex, perceived risk, income, family
history of CRC, education, previous experience of colonoscopy,
previous diagnosis of cancer or polyps, current test outcome),
were also explored before estimating the final choice model. Only
the interaction between test cost and the respondent’s income
was significant. Two income groups were therefore created: in-
come group 1, which had an income of up to AUS$30,000 per year,
and income group 2, which had an income of over AUS$30,000 per
year. Given the age of respondents, a cutoff of AUS$30,000 per
year is approximately equivalent to the median gross house-
hold income of people older than 65 years [45]. The cost attri-
bute was therefore segmented into one attribute for people with
annual income less than AUS$30,000 per year and another for
people with higher incomes. A priori, it would be expected that
the cost of the test would be less important to people with a
higher income (group 2).
Models were evaluated for goodness of fit by using the likeli-
hood ratio 2 statistic for the global test of zero model coefficients,
he McFadden’s pseudo R2, and Akaike’s information criterion. All
model parameters were initially specified as random. To achieve
the most parsimonious model possible, without compromising
model fit, each variable that was nonsignificant as a random pa-
rameter was progressively changed to a fixed parameter, and the
model reestimated. Model fit parameters, and log likelihood, were
assessed after each respecification, and nonrandom parameters
that were nonsignificant were dropped if their removal did not
significantly compromise model fit. Model results are expressed as
parameter estimates (), the odds of preferring CTC to colonos-
opy (and 95% confidence intervals [CIs] of the odds ratios [ORs]),
nd P values. Benefit/harm trade-offs were calculated, and cate-
gorical variables were effects coded. All analyses were conducted
by using NLOGIT Version 4.01 (Econometric Software, Australia,
Castle Hill, NSW, Australia).
Interpretation of the DCE
A positive  coefficient indicates that as the level of that attribute
ncreases, CTC is preferred over colonoscopy (more likely to be cho-
en); a negativecoefficient indicates that as the level of the attribute
CTC Colonoscopy
in 1000 people None—one procedure to diagnose
and treat polyps
imal Intensive
rom 1000 people tested 10 from 1000 people tested
S$100 AUS$0 (no cost)
(please tick one box)
ose CTC Choose colonoscopy
□ □200
Min
40 f
AU
Cho
0
f
a
d
(
c
0
I
e
c
c
p
s
(
i
1149V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 4 6 – 1 1 5 2increases, CTC is less likely to be chosen (colonoscopy is the pre-
ferred test). ORs for the likelihood of preferring CTC over colonos-
copy, given changes in attribute levels, were also calculated. An OR of
greater than 1 indicates that CTC was preferred to colonoscopy,
whereas an OR of less than 1 indicates that colonoscopy was pre-
ferred to CTC (CTC was less preferred).
Results
The DCE was completed by 130 of the 154 patients who were mailed
the questionnaire (response rate of 84.4%). Of these, 35% (46 of 130)
were interviewer-assisted and 65% were self-completed. They were
analyzed as one group as there were no significant differences in the
characteristics of interviewer-assisted and self-completed respon-
dents or in preference models between groups (data not shown). The
practice discrete choice exercise completed by all respondents indi-
cated that respondents understood and correctly interpreted the at-
tributes, their levels, and the DCE question. The demographic char-
acteristics of respondents are presented in Table 3.
Discrete choice preferences
All 130 respondents were included in the discrete choice analyses.
Table 4 shows the results of the final preference model. Test prefer-
ence was significantly influenced by all test attributes and by some
sociodemographic characteristics. The 130 respondents were pre-
sented with a total of 4160 pairwise choice sets; there were missing
data for 28 choice sets. Conventional colonoscopy was chosen in 79%
of all choice sets. This apparent preference for colonoscopy is also
borne out in the choice model data that indicates that most attributes
suggested a preference for colonoscopy over CTC.
Influence of test characteristics
Colonoscopy was preferred over CTC (i.e., CTC was less preferred
than colonoscopy) as the need for a second procedure (colonos-
copy) after CTC increased; as the likelihood of having cancers and
polyps missed by CTC increased; and as the cost of CTC increased.
For every 10% increase in the risk of needing a second procedure
after CTC (i.e., 100 of 1000 people tested), the likelihood of patients
preferring CTC instead of colonoscopy was significantly reduced
(OR 0.013). Similarly, for every 1% increase in the risk of having a
cancer or polyp missed (i.e., 10 of 1000 people tested have a cancer
or a polyp missed), the likelihood of preferring CTC over colonos-
copy was also significantly reduced (OR  0.62). The cost of CTC
was also a significant driver of preference for colonoscopy, par-
ticularly for respondents with lower incomes: for every AUS$10
increase in the out-of-pocket cost associated with CTC, the like-
lihood of choosing CTC over colonoscopy was significantly
lower. The effect of income was stronger for people with lower
incomes (OR  0.65) than for people with higher incomes (OR 
.80). In contrast, the only attribute that led to CTC being pre-
erred over colonoscopy was the type of bowel preparation; with
minimal rather than an intensive bowel preparation, respon-
ents were almost twice as likely to prefer CTC to colonoscopy
OR  1.72).
Influence of sociodemographic factors
Respondents who knew someone with CRC (OR  0.23) or per-
eived their own risk of CRC to be higher than average (OR 
.19) were significantly less likely to prefer CTC to colonoscopy.
ncreasing age was also a significant predictor of lower prefer-
nce for CTC, with an OR of 0.39 for a 10-year increase in age. In
ontrast, those respondents who had previous experience of
olonoscopy (prior to the trial) were significantly more likely to
refer CTC (OR  8.2), while those who had completed high
chool education or above were also more likely to prefer CTCOR  3.4). Family history of CRC and having private health
nsurance did not significantly influence test preference.
Are people willing to trade off benefits and harms?
We also calculated the benefit/harm trade-offs that patients were
willing to accept. To avoid an intensive bowel preparation, respon-
dents were willing to accept, on average, the test’s missing small
cancers or polyps in an additional 16.6 of 1000 people tested (95%
CI  14.9–18.3) and were willing to accept, on average, an addi-
tional 82.3 of 1000 people having to undergo a second procedure
following CTC to treat polyps or cancers (95% CI 67.3–97.3). For a
1% reduction in the risk of missing a small cancer or polyp, people
were willing to accept, on average, an additional 132.7 of 1000
people needing a second procedure after CTC (95% CI  81.4–
184.1).
Discussion
In this study, we use a DCE to assess patient preferences for diag-
nostic CTC and colonoscopy as diagnostic tests for CRC. Our re-
sults suggest that colonoscopy is the preferred diagnostic test for
most people and that patient preferences not only related to the
Table 3 – Characteristics of respondents (n = 130).
Characteristics N %
Mean age (range, SD) 62 (27–84, 13)
Sex (M/F) 61/69 47/53
Education
Did not complete high school 78 60
Completed high school/TAFE/
technical/trade
38 29
Degree (university or college) 14 11
Employment
Full-time 24 19
Part-time/casual 21 16
Home duties 12 9
Retired/pension 67 51
Not working 6 5
Private health insurance 18 14
History of polyps/adenoma 24 18
History of CRC 17 13
Family history of any cancer 71 55
Family history of CRC 27 21
Know someone with CRC 69 53
Self-perceived risk of CRC
A lot/lower than average 52 40
Average 47 36
A lot/higher than average 26 20
Previous experience of conventional
colonoscopy (before trial entry)
58 45
Household income (per annum)
(n  113)
AUS$20,000 66 58
AUS$20,000–AUS$30,000 22 19
AUS$30,001–AUS$50,000 12 11
AUS$50,000 13 12
Mean postprocedure pain/discomfort
rating for CTC (0  none, 5  a
great deal) (SD)
1.94 (1.01)
Mean postprocedure pain/discomfort
rating for colonoscopy (SD)
1.63 (0.87)
CRC, colorectal cancer; CTC, computed tomography colonography;
TAFE, Technical and Further Education.characteristics of the tests but also were associated with sociode-
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knowledge of people who have CRC, previous experience of
colonoscopy, and income.
Our results indicate that patients would prefer a test with a
lower chance of needing a second procedure, a minimal instead of
intensive bowel preparation, a lower chance of missing cancers or
polyps, and a lower out-of-pocket cost.
In relation to the need for a second procedure, an increase in
Table 4 – Results from the final preference model, model co
colonoscopy).
Variables  coe
Random parameters
The likelihood of needing a second procedure after CTC
to treat polyps or cancer (for every 100 extra people
requiring a second procedure)
Mean 4
SD 3
Minimal (compared with intensive) bowel preparation
Mean 0
SD 0
Chance of missing small cancers (per 10 extra people
with cancers or polyps missed by CTC)
Mean 0
SD 0
Out-of-pocket cost (income  AUS$30,000) (for every $10
increase in cost)
Mean 0
SD 0
Out-of-pocket cost (income  AUS$30,000) (for every $10
increase in cost)
Mean 0
SD 0
Age (for every 10-year increase in age of respondents)
Mean 0
SD 0
Higher than average self-perceived risk of colorectal
cancer (vs. average/less than average risk)
Mean 1
SD 1
Know someone with colorectal cancer (yes vs. no)
Mean 1
SD
Had a previous conventional colonoscopy (yes vs. no)
Mean 2
SD 3
Nonrandom parameters
Constant
Mean 7
Has private health insurance (yes vs. no)
Mean 0
Family history of colorectal cancer (yes vs. no)
Mean 0
Education level (completed high school or above vs. did
not complete high school)
Mean 1
McFadden’s R2 (pseudo R2)† 0
Akaike’s information criterion 0
Log likelihood 475
CTC, computed tomography colonography.
* Odds of choosing CTC compared with colonoscopy per specified un
† The mixed-logit model is statistically significant in predicting patie
of  0.00001]).the likelihood of needing colonoscopy after CTC was associated dwith a substantial decrease in the odds of preferring CTC. This
indicates that respondents valued the fact that colonoscopy could
complete the diagnostic and therapeutic components in one pro-
cedure. It is also consistent with qualitative studies [46] showing
hat patients perceived a second diagnostic procedure as not only
nconvenient but also responsible for delaying diagnosis and
reatment. Despite this, however, some people were willing to ac-
ept an increase in the number of people needing a second proce-
ients, and odds of choosing CTC (compared with
ent P value Odds ratio* (95% confidence interval)
5 .00001 0.0130 (0.0046–0.5989)
9 .00001
66 .0001 1.7233 (1.3015–2.2820)
03 .00001
78 .0030 0.6153 (0.4716–0.8778)
21 .00001
42 .00001 0.6518 (0.5916–0.9536)
42 .00001
78 .00001 0.8047 (0.7610–0.9730)
78 .00001
13 .00001 0.3908 (0.2685–0.8320)
2 .00001
2 .0129 0.1859 (0.0494–0.7002)
.0951
3 .0064 0.2330 (0.0818–0.6637)
97 .2179
2 .0002 8.2385 (2.7231–24.9247)
4 .00001
5 .00001
2 .2065 0.4483 (0.1291–1.5564)
15 .3064 1.5676 (0.6624–3.7098)
1 .00001 3.4243 (2.1812–5.3759)
ange in attribute.
ferences with a pseudo R2 of 0.82 (2 4387 [with 20 df and a P valueeffic
ffici
.3425
.2238
.5442
.7073
.4855
.7484
.4279
.4279
.2172
.2172
.9395
.3883
.6823
.4102
.4568
.8274
.1088
.9009
.2607
.8022
.4495
.2309
.822
.263
.27
it ch
nt preure if it meant a lower chance of missing a cancer or polyp.
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spondents were almost twice as likely to choose CTC over colono-
scopy if there was an option of minimal bowel preparation. This is
consistent with other studies indicating that bowel preparation is
the most inconvenient aspect of the tests [18,19,46]. Indeed, some
patients were willing to accept increases in the number of people
needing a second procedure or a reduction in diagnostic accuracy
for a less intensive bowel preparation.
Patient preferences were also significantly influenced by test
accuracy (the likelihood of missing small cancers or polyps). There
is often an underlying assumption by patients that a newer test is
a more accurate test [46]. Our study and others [46], however, have
shown that even small changes in test accuracy can significantly
influence diagnostic test preference. Patients were willing to ac-
cept an increase in the number of people undergoing a second
procedure to lower the risk of missing cancers or polyps.
Sociodemographic factors were also generally consistent with
a priori expectations. Respondents with a higher income were less
concerned with test cost, compared with those with a lower in-
come. Furthermore, people who knew someone with CRC and per-
ceived their own risk of CRC to be higher than average were more
likely to prefer colonoscopy. In contrast, those who had experi-
enced a previous colonoscopy before trial entry were less likely to
want to repeat that experience and showed a stronger preference
for CTC.
The literature reports significant heterogeneity of preferences for
diagnostic CTC and colonoscopy, some favoring CTC [10–15,17] and
others favoring colonoscopy [8,9,19,46,47]. This variability indicates
that individual preferences are important and should be one of the
primary considerations in deciding the most appropriate diagnostic
test for a given patient. It also suggests that different patients are
willing to accept different levels of trade-offs between what they
perceive as the advantages and disadvantages of the tests, and there-
fore a “one test fits all” approach is unlikely to be appropriate. To
facilitate informed patient decision making, we therefore need to not
only understand what attributes influence test preference, and their
relative importance to patients, but also the extent to which patients
are likely to accept trade-offs between attributes, such that the most
relevant information can be provided to patients.
Overall this study provides a better understanding of the deci-
sion-making process of patients— it goes beyond simply asking
which test is preferred and provides insights into why one test
might be preferred over another and the benefit/harm trade-offs
patients are willing to make in choosing a diagnostic test. Test
preferences can change, depending on the amount and type of
information and the method of presentation [46]. There is a danger
in assuming that the “newest” test or the “least invasive” test will
be the most preferred by patients [46]. Our study demonstrates
that is not always the case, with the majority of patients preferring
colonoscopy to CTC when provided with explicit information
about potential benefits, downsides, and uncertainties of both
tests. Although the results of this study should not be seen as
replacing a discussion of an individual patient’s preference, it may
help clinicians target the type of information that is most relevant
for patients and thereby support informed decision making in the
context of a clinical encounter. Much has been written about the
importance of informed decision making and shared decision
making in the context of screening decisions [45,48–52]. Similar
consideration should be given to the provision of information for
patients making decisions about which diagnostic test to undergo.
Our study indicates that patients are willing and able to incorpo-
rate somewhat complex numerical information regarding poten-
tial benefits, downsides, and uncertainties of diagnostic tests, and
therefore should be given the opportunity to do so in the context of
a clinical consultation where alternative diagnostic tests are being
considered. If we do not provide patients with comprehensive in-
formation of the potential benefits, downsides, and uncertaintiesassociated with diagnostic tests, and we fail to appreciate the
trade-offs between them that patients are willing to accept, we run
the risk of assuming that patients will prefer the newest and “least
invasive” test [46], and thus risk providing care that is not aligned
with true patient preferences.
Although there have been a number of studies examining
stated preferences for CTC as a screening test, to our knowledge,
this is the first study to elicit preferences for CTC or colonoscopy as
diagnostic tests using a DCE. This distinction between screening
and diagnosis is important because the clinical context in which a
decision is being made is likely to influence the value attached to
various attributes and the benefit/harm trade-offs that are accept-
able to patients. Our analysis uses best practice modeling methods
and estimates the trade-offs people are willing to make between
the perceived advantages and disadvantages of the diagnostic
tests.
A number of limitations, however, should be borne in mind.
First, our analysis is limited to the preferences of patients who had
experienced both tests as diagnostic tests. This has the advantage
that respondents have a better understanding of the actual tests,
but preferences of these patients may not be the same as those of
patients who have not experienced CTC or colonoscopy. This
study also specifically considers preferences for CTC and colono-
scopy as diagnostic tests. In the context of a screening decision,
there are likely to be differences in the importance of attributes
and in particular, differences in the trade-offs that people are will-
ing to accept; these have been considered by other authors [20–
22,53]. Our attributes were based on qualitative and quantitative
data from our specific patient group. In different respondent
populations, however, other attributes, such as complication
rates or exposure to radiation with CTC, may also influence
preferences, despite the fact that these factors did not seem to
be particularly important to our patients. In calculating attri-
bute levels, we have assumed that all patients with lesions on
CTC will be advised to have colonoscopy. This issue continues
to be debated because some physicians recommend colonos-
copy only for patients with lesions 5 mm or even 10 mm in
diameter. Finally, our analysis was restricted to the preferences
of patients at one, albeit large, hospital in Australia. Preferences
may vary across countries and health systems and might also be
influenced by local factors such as levels of sedation available
with colonoscopy, or even staff characteristics [54].
Despite CTC’s often being perceived as a test that patients will
prefer over colonoscopy, this study suggests that this is not always
the case. Informed decision making for diagnostic tests for CRC
should therefore include discussion of the benefits, downsides, and
uncertainties associated with alternative tests, because patients are
willing and able to make trade-offs between what they perceive as
the advantages and disadvantages of these diagnostic tests. Clearly,
DCE results are not a direct substitute for establishing individual
preferences in the context of a clinical consultation; however, our
data may help inform a discussion of diagnostic testing options with
patients and in turn facilitate an informed test choice.
Source of financial support: This study of patient preferences
was funded by the Australian National Health and Medical Re-
search Council, Program Grants 211205 and 402764 for the Screen-
ing and Test Evaluation Program. The Virtual Colonoscopy (diag-
nostic accuracy) Study was funded by the South Australian
Department of Health. Prof Pignone was supported by a Packer
Policy Fellowship from The Commonwealth Fund. The funders
had no role in the design and conduct of the study; collection,
management, analysis, and interpretation of the data; or prepara-
tion, review, or approval of the manuscript. Dr. Howard had full
access to all the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis.
[[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
1152 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 4 6 – 1 1 5 2R E F E R E N C E S
[1] Ransohoff DF. Virtual colonoscopy—what it can do vs what it will do.
JAMA 2004;291:1772–4.
[2] Mehrez A, Gafni A. Preference based outcome measures for economic
evaluation of drug interventins: quality-adjusted life years (QALYs)
versus healthy-years equivalents (HYEs). Pharmacoeconomics 1992;1:
338–45.
[3] Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed
tomographic colonography. Ann Intern Med 2005;142:635–50.
[4] Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air
contrast barium enema and colonoscopy. Am J Med 2007;120:203–10.
[5] Serlie IW, de Vries AH, van Vliet LJ, et al. Lesion conspicuity and
efficiency of CT colonography with electronic cleansing based on a three-
material transition model. AJR Am J Roentgenol 2008;191:1493–502.
[6] Walleser S, Griffiths A, Lord SJ, et al. What is the value of computered
tomography colonography in patients screening positive for fecal
occult blood? A systematic review and economic evaluation. Clin
Gastroenterol Hepatol 2007;5:1439–46.
[7] Mavranezouli I, East JE, Taylor SA. CT colonography and cost-
effectiveness. Euro Radiol 2008;18:2485–97.
[8] Akerkar GA, Yee J, Hung R, McQuaid K. Patient experience and
preferences toward colon cancer screening: a comparison of virtual
colonoscopy and conventional colonoscopy. Gastrointest Endosc 2001;
54:310–5.
[9] Angtuaco TL, Banaad-Omiotek GD, Howden CW. Differing attitudes
toward virtual and conventional colonoscopy for colorectal cancer
screening: surveys among primary care physicians and potential
patients. Am J Gastroenterol 2001;96:887–93.
[10] Svensson MH, Svensson E, Lasson A, Hellstrom M. Patient acceptance
of CT colonography and conventional colonoscopy: prospective
comparative study in patients with or suspected of having colorectal
disease. Radiology 2002;222:337–45.
11] Thomeer M, Bielen D, Vanbeckevoort D, et al. Patient acceptance for
CT colonography: what is the real issue? Euro Radiol 2002;12:1410–5.
12] Juchems MS, Ehmann J, Brambs HJ, Aschoff AJ. A retrospective
evaluation of patient acceptance of computed tomography
colonography (’virtual colonoscopy’) in comparison with conventional
colonoscopy in an average risk screening population. Acta Radiologica
2005;46:664–70.
13] Taylor SA, Halligan S, Burling D, et al. Intra-individual comparison of
patient acceptability of multidetector-row CT colonography and
double-contrast barium enema. Clin Radiol 2005;60:207–14.
14] Taylor SA, Halligan S, Saunders BP, et al. Acceptance by patients of
multidetector CT colonography compared with barium enema
examinations, flexible sigmoidoscopy, and colonoscopy. AJR 2003;181:
913–21.
15] van Gelder RE, Birnie E, Florie J, et al. CT colonography and
colonoscopy: assessment of patient preference in a 5-week follow-up
study. Radiology 2004;233:328–37.
16] Ristvedt SL, McFarland EG, Weinstock LB, Thyssen EP. Patient
preferences for CT colonography, conventional colonoscopy, and
bowel preparation. Am J Gastroenterol 2003;98:578–85.
17] Liedenbaum MH, van Rijn AF, de Vries AH, et al. Using CT
colonography as a triage technique after a positive faecal occult blood
test in colorectal cancer screening. Gut 2009;58:1242–9.
18] Beebe TJ, Johnson CD, Stoner SM, et al. Assessing attitudes toward
laxative preparation in colorectal cancer screening and effects on
future testing: potential receptivity to computed tomographic
colonography. Mayo Clinic Proc 2007;82:666–71.
19] Hawley ST, Volk RJ, Krishnamurthy P, et al. Preferences for colorectal
cancer screening among racially/ethnically diverse primary care
patients [see comment]. Med Care 2008;46(9, Suppl. 1):S10–6.
20] Marshall DA, Johnson FR, Phillips KA, et al. Measuring patient
preferences for colorectal cancer screening using a choice-format
survey. Value Health 2007;10:415–30.
21] Marshall DA, McGregor E, Currie G. Measuring preferences for
colorectal cancer (CRC) screening–what are the implications for
moving forward? Patient 2010;3:79–89.
22] Salkeld G, Solomon M, Short L, et al. Evidence-based consumer choice:
a case study in colorectal cancer screening. Aust N Z J Public Health
2003;27:449–55.
23] Roberts-Thomson IC, Tucker GR, Hewett PJ, et al. Single-center study
comparing computed tomography colonography with conventional
colonoscopy. World J Gastroenterol 2008;14:469–73.
24] Lancsar E, Louviere J. Conducting discrete choice experiments to
inform healthcare decision making: a user’s guide.
Pharmacoeconomics 2008;26:661–77.[25] Bridges JF, Kinter E, Kidane L, et al. Things are looking up since we
started listening to patients: recent trends in the application of
conjoint analysis in health 1970–2007. Patient 2008;1:273–82.
[26] Bridges JF, Hauber AB, Marshall DA, et al. Conjoint analysis
applications in health—a checklist: a report of the ISPOR Good
Research Practices for Conjoint Analysis Task Force. Value Health
2011;14:403–13.
[27] Edwards A, Elwyn G, Covey J, et al. Presenting risk information—a
review of the effects of ’framing’ and other manipulations on patient
outcomes. J Health Communication 2001;6:61–82.
[28] Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical
data into meaningful pictures. BMJ 2002;324:827–30.
[29] Gigerenzer G, Todd PM, The ABC Research Group. Simple Heuristics
that Make Us Smart. New York, NY: Oxford University Press; 1999.
[30] Charalambopoulos A, Syrigos KN, Ho JL, et al. Colonoscopy in
symptomatic patients with positive family history of colorectal
cancer. Anticancer Res 2000;20:1991–4.
[31] de Bosset V, Froehlich F, Rey JP, et al. Do explicit appropriateness
criteria enhance the diagnostic yield of colonoscopy? Endoscopy 2002;
34:360–8.
[32] Dowling DJ, St John DJ, Macrae FA, Hopper JL. Yield from colonoscopic
screening in people with a strong family history of common colorectal
cancer. J Gastroenterol Hepatol 2000;15:939–44.
[33] Laghi A, Iannaccone R, Carbone I, et al. Computed tomographic
colonography (virtual colonoscopy): blinded prospective comparison
with conventional colonoscopy for the detection of colorectal
neoplasia. Endoscopy 2002;34:441–6.
[34] Neugut AI, Garbowski GC, Waye JD, et al. Diagnostic yield of colorectal
neoplasia with colonoscopy for abdominal pain, change in bowel
habits, and rectal bleeding. Am J Gastroenterol 1993;88:1179–83.
[35] Syrigos K, Charalampopoulos A, Ho J, et al. Colonoscopy in
asymptomatic patients with a family history of colorectal cancer. Ann
Surg Oncol 2002;9:439–43.
[36] Ure T, Dehghan K, Vernava AM III, et al. Colonoscopy in the elderly.
Low risk, high yield. Surg Endoscopy 1995;9:505–8.
[37] Gilbert JM, Vaizey CJ, Cassell PG, Holden J. Feasibility study of
colonoscopy as the primary screening investigation in relatives of
patients with colorectal cancer. Ann R Coll Surg Engl 2001;83:415–9.
[38] Dykes CM. Virtual colonoscopy: a new approach for colorectal cancer
screening. Gastroenterol Nurs 2001;24:5–11.
[39] Fenlon HM. Colorectal neoplasm detection using virtual colonoscopy:
a feasibility study. Gastrointest Endosc 2000;51:369–71.
[40] Mendelson RM, Foster NM, Edwards JT, et al. Virtual colonoscopy
compared with conventional colonoscopy: a developing technology.
Med J Australia 2000;173:472–5.
[41] Pescatore P, Glucker T, Delarive J, et al. Diagnostic accuracy and
interobserver agreement of CT colonography (virtual colonoscopy).
Gut 2000;47:126–30.
[42] Spinzi G, Belloni G, Martegani A, et al. Computed tomographic
colonography and conventional colonoscopy for colon diseases: a
prospective, blinded study. Am J Gastroenterol 2001;96:394–400.
[43] Hensher DA, Greene WH. The mixed logit model: the state of practice.
Transportation 2003;30:133–76.
[44] Hensher DA, Rose JM, Greene WH. Applied Choice Analysis. A Primer
(1st ed.). Cambridge: Cambridge University Press; 2005.
[45] Welch HG, Welch HG. Informed choice in cancer screening. JAMA
2001;285:2776–8.
[46] von Wagner, Halligan S, Atkin WS, et al. Choosing between CT
colonography and colonoscopy in the diagnostic context: a qualitative
study of influences on patient preferences. Health Expect 2009;12:18–26.
47] Bosworth HB, Rockey DC, Paulson EK, et al. Prospective comparison of
patient experience with colon imaging tests. Am J Med 2006;119:791–9.
48] Jepson RG, Hewison J, Thompson AG, et al. How should we measure
informed choice? The case of cancer screening. J Med Ethics 2005;31:192–6.
49] Shokar NK, Carlson CA, Weller SC, et al. Informed decision making
changes test preferences for colorectal cancer screening in a diverse
population. Ann Family Med 2010;8:141–50.
50] Irwig L, McCaffery K, Salkeld G, et al. Informed choice for screening:
implications for evaluation. BMJ 2006;332:1148–50.
51] Denberg TD, Wong S, Beattie A, et al. Women’s misconceptions about
cancer screening: implications for informed decision-making. Patient
Educ Couns 2005;57:280–5.
52] Edwards AG, Evans R, Dundon J, et al. Personalised risk
communication for informed decision making about taking screening
tests. Cochrane Database Syst Rev 2006;(4):CD001865.
53] Hol L, de Bekker-Grob EW, van DL, et al. Preferences for colorectal
cancer screening strategies: a discrete choice experiment. Br J Cancer
2010;102:972–80.
54] von Wagner C, Knight K, Halligan S, et al. Patient experiences of
colonoscopy, barium enema and CT colonography: a qualitative study.
Br J Radiol 2009;82:13–9.
